Allergy treatment shifts toward precision medicine with tailored immunotherapy, new guidance shows

Until recently, allergy treatment was largely based on average treatment schemes. A patient with pollen allergy would receive a similar therapy to others with the same diagnosis. Today, this model is beginning to change. The latest recommendations published by the European Academy of Allergy and Clinical Immunology in the journal Allergy show that allergen immunotherapy (AIT) is entering the era of precision medicine, and with it, the way we think about allergy itself is evolving.